NovAccess Global Inc XSNX:OTCPK

RT Quote | Exchange | USD
Last | 02/26/21 EST
0.4701quote price arrow up+0.0001 (+0.02%)
Volume
6,711
52 week range
0.20 - 1.40

...

Loading . . .

KEY STATS

  • Open0.47
  • Day High0.4701
  • Day Low0.462
  • Prev Close0.47
  • 52 Week High1.40
  • 52 Week High Date08/26/20
  • 52 Week Low0.20
  • 52 Week Low Date08/11/20
  • Market Cap4.28M
  • Shares Out9.10M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • 1 Year % Change-5.98

RATIOS/PROFITABILITY

  • EPS (TTM)0.15
  • P/E (TTM)3.13
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-635,590.00
  • ROE (MRQ)-
  • Revenue (MRQ)450,000.00
  • Gross Margin (MRQ)56.61%
  • Net Margin (MRQ)298.20%
  • Debt To Equity (MRQ)-18.25%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest NovAccess Global Inc News

There is no recent news for this security.

Latest XSNX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
NovAccess Global, Inc., formerly XsunX, Inc., is a biomedical company. The Company focuses to provide diagnostics and therapeutics for cancer and neurological diseases. The Company utilizes immunotherapy approaches to enhance the patient’s own immune cells to recognize and kill cancer cells. It is engaged in developing technology that utilizes artificial intelligence platforms to provide personalized and patient-centered care. Its technology, StemVax Therapeutics, has an...
Daniel Martin
Chairman
Dwain Irvin
Chief Executive Officer
L. Michael Yukich
Chief Financial Officer
Address
8834 MAYFIELD RD
Chesterland, OH
44026
United States